H. Heinrichs

High-Dose Antithrombin III in Severe Sepsis

Brian Warren, Alain Eid, Pierre Singer et al. · JAMA · 2001 · 1.4K citations

Medicine, Pharmacology, Pharmacotherapy +17

Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study

Ulrich Bogdahn, Peter Hau, Günther Stockhammer et al. · Neuro-Oncology · 2010 · 428 citations · Full text

Medicine, Oncology, Pharmacology +16

Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HIT-III) study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK)

K. L. Neuhaus, R. von Essen, Ulrich Tebbe et al. · Circulation · 1994 · 283 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Extraembryonic expression of the human MHC class I gene HLA-G in transgenic mice. Evidence for a positive regulatory region located 1 kilobase 5' to the start site of transcription.

Cynthia Schmidt, Robert Ehlenfeldt, Lisa Duvick et al. · The Journal of Immunology · 1993 · 59 citations

Life Sciences, Genetics, Immunology +14

Antithrombin III in patients with severe sepsis: a pharmacokinetic study

W. Ilias, W. F. List, Johan Decruyenaere et al. · Intensive Care Medicine · 2000 · 57 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +14